Page last updated: 2024-10-31

naphazoline and Epilepsy

naphazoline has been researched along with Epilepsy in 2 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research Excerpts

ExcerptRelevanceReference
"Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures."5.27Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987)
"Nafimidone is a new antiepileptic drug which may be effective in partial onset seizures."1.27Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy. ( Gunawan, S; Treiman, DM, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sari, S1
Barut, B1
Marcinkowska, M1
Sabuncuoğlu, S1
Avci, A1
Koçak Aslan, E1
Özel, A1
Siwek, A1
Treiman, DM1
Gunawan, S1

Other Studies

2 other studies available for naphazoline and Epilepsy

ArticleYear
Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations.
    Drug development research, 2022, Volume: 83, Issue:1

    Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Epilepsy; Mice; Mol

2022
Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
    Clinical pharmacokinetics, 1987, Volume: 12, Issue:6

    Topics: Adult; Anticonvulsants; Chronic Disease; Epilepsy; Female; Half-Life; Humans; Imidazoles; Kinetics;

1987